Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata available, Park Infusioncare LP (operating as Preferred Homecare) received an FDA Warning Letter on March 1, 2018, regarding their operations as a homecare infusion services company. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the metadata provided. The warning falls under FDA's regulatory oversight of infusion care products and services, though the specific issuing office and detailed violation count are not documented in the available information. To understand the full scope of regulatory concerns, the complete Warning Letter text would be needed.